431
Views
5
CrossRef citations to date
0
Altmetric
Articles

PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines

ORCID Icon, , , , ORCID Icon &
Pages 1661-1669 | Received 02 Feb 2021, Accepted 08 Feb 2021, Published online: 21 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stefano Dastoli, Maria Passante, Francesco Loconsole, Edoardo Mortato, Anna Balato, Vincenzo Piccolo, Claudio Guarneri, Laura Macca, Eugenio Provenzano, Giancarlo Valenti, Domenico D’Amico, Giuseppe Micali, Maria Letizia Musumeci, Giovanni Palazzo, Caterina Foti, Paolo Romita, Gabriella Fabbrocini, Matteo Megna, Ilaria Sammarra, Luigi Bennardo & Cataldo Patruno. (2023) Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy. Journal of Dermatological Treatment 34:1.
Read now

Articles from other publishers (4)

Lisa Schots, Rani Soenen, Brigitte Blanquart, Debby Thomas & Jo Lambert. (2023) Blocking interleukin‐17 in psoriasis: Real‐world experience from the PsoPlus cohort . Journal of the European Academy of Dermatology and Venereology 37:4, pages 698-710.
Crossref
Paulo Antônio Oldani Felix, Ana Luisa Sampaio, Bruno Leonardo Silva & Analia Luiza Porto Viana. (2022) Early intervention in psoriasis: Where do we go from here?. Frontiers in Medicine 9.
Crossref
A. David Burden, Siew Eng Choon, Alice B. Gottlieb, Alexander A. Navarini & Richard B. Warren. (2022) Clinical Disease Measures in Generalized Pustular Psoriasis. American Journal of Clinical Dermatology 23:S1, pages 39-50.
Crossref
Deborah Cull, Joseph Pena, Esther A. Balogh, Caitlin G. Purvis & Steven R. Feldman. 2022. Biologic Therapy for Psoriasis. Biologic Therapy for Psoriasis 101 110 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.